MEDICLINIC INTERNATIONAL PLC

Major Shareholding Notification • May 11, 2017

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9180E

Mediclinic International PLC

11 May 2017

Mediclinic International plc

(Incorporated in England and Wales)

Company Number 8338604

LSE Share Code: MDC

JSE Share Code: MEI

NSX Share Code: MEP

ISIN: GB00B8HX8Z88

LEI: 2138002S5BSBIZTD5I60

11 May 2017

Notification of Major Interest in Mediclinic International plc shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:											Mediclinic International plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights																	x
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation:									Coronation Asset Management (Pty) Ltd
4. Full name of shareholder(s)  (if different from 3.):									N/A
5. Date of the transaction and date on which the threshold is crossed or reached:									11 May 2017
6. Date on which issuer notified:									11 May 2017
7. Threshold(s) that is/are crossed or reached:									5%
8. Notified details:
A: Voting rights attached to shares
Class/type of shares if possible using the ISIN CODE	Situation previous to the triggering transaction							Resulting situation after the triggering transaction
Number of Shares				Number of Voting Rights			Number of shares			Number of voting rights			% of  voting rights
Direct			Direct		Indirect	Direct		Indirect
GB00B8HX8Z88	37 306 089				37 306 089			36 139 844			36 139 844			4.90%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument				Expiration date		Exercise/ Conversion Period					Number of voting rights that may be acquired if the instrument is exercised/ converted.				% of voting rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument		Exercise price			Expiration date		Exercise/ Conversion period				Number of voting rights instrument refers to				% of voting rights
															Nominal		Delta
Total (A+B+C)
Number of voting rights										Percentage of voting rights
36 139 844										4.90%
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
Proxy Voting:
10. Name of the proxy holder:												Coronation Asset Management (Pty) Ltd
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:
14. Contact name:										Jamie Rowland
15. Contact telephone number:										+27 21 680 2000

Mediclinic's primary listing is on the Main Market of the LSE, with secondary listings on the JSE in South

Africa and on the NSX in Namibia.

Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom

Website: www.mediclinic.com

Corporate broker: Morgan Stanley & Co International plc

JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)

NSX sponsor: Simonis Storm Securities (Pty) Ltd

For further information please contact:

Mediclinic International plc

James Arnold, Head of Investor Relations

ir@mediclinic.com

Capita Company Secretarial Services Limited

Victoria Dalby

+44 (0)207 954 9600

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLUAOSRBAAVAAR